ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12572 recruiting trials
Use of CXCL9 as a Biomarker of Acthar Efficacy
👨⚕️ Laura Koth, MD, University of California, San Francisco📍 1 site📅 Started Nov 2022View details ↗
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
RecruitingNCT05600842 ↗
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Tetracycline Treatment Tolerability Trial
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
🏥 Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT07181070 ↗
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
RecruitingNCT06462430 ↗
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Quantifying Hepatic Mitochondrial Fluxes in Humans
👨⚕️ Luke Norton, PhD, The University of Texas Health Science Center at San Antonio📍 2 sites📅 Started Nov 2022View details ↗
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
👨⚕️ Jonathan C Roberts, MD, Bleeding and Clotting Disorders Institute📍 9 sites📅 Started Nov 2022View details ↗
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Enrolling by InvitationNCT05812339 ↗
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
👨⚕️ Christopher N Andrews, MD MSc FRCPC, University of Calgary📍 1 site📅 Started Nov 2022View details ↗
Behavioral Activation + Occupational Therapy: An Innovative Intervention for Empowered Self-Management of Multiple Chronic Conditions
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma
RecruitingNCT05593679 ↗
A Multi-center Cardiac PYP Scan Registry in Taiwan
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma
👨⚕️ Shuhua Yi, Dr, Institute of Hematology & Blood Diseases Hospital, Chinese📍 1 site📅 Started Nov 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →